![Uli Kohli](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Uli Kohli
Directeur/Membre du Conseil chez Ellenborough Park Hotel
Provenance du réseau au premier degré de Uli Kohli
Entité | Type d'entité | Industrie | |
---|---|---|---|
Ellenborough Park Hotel
![]() Ellenborough Park Hotel Hotels/Resorts/Cruise linesConsumer Services Part of Shetland Business Ltd., Ellenborough Park Hotel is a luxury 5-star hotel located in Cheltenham, UK. In addition to its luxurious accommodations, Ellenborough Park Hotel also offers exciting activities such as husky driving and archery to showcase the best of the Cotswolds. Founded in 2008, the hotel offers a uniquely charming corporate meeting event venue, spa, and a range of dining options including alfresco dining.
2
| Subsidiary | Hotels/Resorts/Cruise lines | 2 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Uli Kohli via son réseau personnel
Société | Secteur | Personnes liées | Poste principal |
---|---|---|---|
Immodulon Therapeutics Ltd.
![]() Immodulon Therapeutics Ltd. BiotechnologyHealth Technology Part of Lifexx SA, Immodulon Therapeutics Ltd. is a late-stage clinical biotechnology company based in Uxbridge, UK. Immodulon is developing a highly differentiated cancer immunotherapy approach that primes the patient’s own innate immune system with the aim to significantly enhance the efficacy of a broad range of anti-cancer therapies, including chemotherapy and checkpoint inhibitors. The British company is developing imm-101, a heat-killed mycobacterium obuense, as a broad-spectrum immunomodulatory agent with the potential to treat a range of difficult-to-treat tumors including those considered to be immunologically “ cold, ” such as pancreatic cancer. Immodulon's imm-101 based immunotherapy complements other cancer therapies, including immune checkpoint inhibitors and chemotherapy. The company is focused on developing safe and effective immunotherapy treatments. The company was founded in 2007 by Charles Akle, John L. Stanford. Gertjan Bartlema has been the CEO of the company since 2022. | Biotechnology | Director/Board Member | |
Liwet Holding AG
![]() Liwet Holding AG Financial ConglomeratesFinance Liwet Holding AG engages in the acquisition, holding, management, and sale of participations in domestic and foreign companies. It also provides financing services. The company was founded on April 27, 2010 and is headquartered in Zurich, Switzerland. | Financial Conglomerates | Director/Board Member |
Statistiques
Internationale
Royaume-Uni | 2 |
Suisse | 2 |
Sectorielle
Health Technology | 2 |
Finance | 2 |
Opérationnelle
Director/Board Member | 4 |